"Lumify generated $66 million of revenue, up 38%" (Executive VP & CFO Eldessouky). "Third quarter revenue was $234 million, up 9% versus the prior year" (Executive VP & CFO Eldessouky). "Implantables ...
Fintel on MSN
Bausch + Lomb reports third-quarter 2026 revenue of $1.375 billion and raises full-year guidance
Bausch + Lomb Corporation reported total revenue of $1.375 Billion for the third quarter of 2026, as compared to $1.281 billion in the third quarter of 2025, an increase of 7%. Excluding the ...
Bausch + Lomb (BLCO) delivered earnings and revenue surprises of +61.91% and +0.14%, respectively, for the quarter ended ...
Net Income Net income attributable to Bausch + Lomb Corporation for the third quarter of 2026 was $32 million, as compared to a $28 million loss for the third quarter of 2025, a favorable change of ...
Bausch + Lomb beat analysts’ revenue expectations last quarter, reporting revenues of $1.39 billion, up 9.1% year on year. It ...
Prof Min Kim, one of South Korea’s leading vitreoretinal surgeons, notes meaningful advantages in the new BIOM 6 viewing ...
Bausch + Lomb announced that CEO and director Brent Saunders left the company and its board on October 12, 2026. Board ...
Bausch + Lomb Corp. has appointed Thomas J. Appio interim CEO, succeeding Brent Saunders, who has led the company since 2023. Saunders and the board mutually agreed that he would depart from the ...
Brent Saunders' second stint as chief executive of eye care company Bausch + Lomb has come to an end. He is stepping down immediately from the role – by mutual agreement with the board of directors – ...
Oct 12 (Reuters) - Bausch + Lomb (BLCO.TO), opens new tab said on Monday that CEO Brent Saunders will leave the eye-care company by mutual agreement with its board, sending its US-listed shares down ...
Brent Saunders is stepping down as Bausch + Lomb’s CEO through mutual agreement with the company’s board, Bausch announced Monday. (Mike Coppola/Getty Images) Less than four years after returning to ...
Bausch + Lomb and Bausch Health Announce Appointment of Thomas J. Appio as Interim Bausch + Lomb CEO, Expect to Raise Full-Year 2026 Guidance Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results